Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib

Annals of Surgical Oncology
Changhoon YooYoon-Koo Kang

Abstract

Although genetic p53 aberrations are correlated with the prognosis of various types of cancer, their prognostic relevance is currently unclear in patients with gastrointestinal stromal tumors (GISTs) of the small intestine. Between 1994 and 2008, 113 patients with resected localized GISTs of the small intestine were included in this analysis. Patients who received pre- and/or postoperative chemotherapy were excluded. p53 overexpression was assessed by immunohistochemical staining and defined as expression in >10 % of tumor cells. p53 overexpression was identified in 38 patients (34 %) and was significantly associated with epithelioid histology (p = 0.040) and high cellularity (p = 0.004). Relapse-free survival (RFS) significantly differed according to p53 overexpression (5-year RFS rates, 57 vs. 78 %; p = 0.005). By multivariate analysis, which included tumor necrosis, tumor size, mitotic count, and primary genotype, p53 overexpression significantly affected RFS with a hazard ratio of 3.50 (95 % confidence interval 1.48-8.25; p = 0.004). p53 overexpression is an independent prognostic factor in patients with small intestinal GISTs. This suggests that p53 expression can be used to further stratify recurrence risk in patients wit...Continue Reading

References

Feb 8, 2002·Cell·Ricky W JohnstoneScott W Lowe
Jul 3, 2002·Human Pathology·Christopher D M FletcherSharon W Weiss
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina R AntonescuPeter Besmer
Dec 30, 2006·Seminars in Diagnostic Pathology·Markku Miettinen, Jerzy Lasota
Mar 24, 2009·Lancet·Ronald P DematteoUNKNOWN American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Salvatore RomeoUNKNOWN European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Dec 31, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L ZongY Xu
Mar 29, 2012·JAMA : the Journal of the American Medical Association·Heikki JoensuuPeter Reichardt
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher L CorlessRonald P DeMatteo

❮ Previous
Next ❯

Citations

Nov 23, 2016·World Journal of Surgery·Jun Ho LeeJin Cheon Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.